It’s been 19 years now, yet every morning I wake up, feel the tingling and wonder, maybe just for a few seconds.

The value of monitoring a chronic disease

Metastatic breast cancer is now considered a chronic condition with effective treatments that in many ways allow women to lead a normal or near normal life. Yet, many women live with the fear that their cancer may no longer be responding to medication or the disease has flared in advance of overt clinical symptoms. We believe that a simple blood test can effectively monitor medication and help detect recurrences of HER2 tumors. Plus, monitoring helps to reduce anxiety. Therein lies the value of monitoring serum HER2 for women with metastatic HER2 tumors--the possibility of real-time, actionable information and additional peace of mind.

About Martell Diagnostic

Martell Diagnostic Laboratories


Founded: 2008

Business model: reference laboratory

Ownership: venture-backed

Location: Roseville, MN

Selected News

Executive Appointments
(Fall 2017)
The board of directors is pleased to announced Dr. Steven P. Stoesz as President and Chief Operating Officer, and Frank R. McEvoy as Chief Financial Officer. Anthony Wlazlow, Ph.D., has also joined Martell as head of Product Development.

Martell signs Laboratory Service Agreement with Moffitt Cancer Center 

(October 2017)
The Company will support a Phase II clinical trial of a new anti-HER2 drug combination.

Target Oncology Marketing Agreement

(October 2016)
We engaged a national network of oncology sales representatives. 

Welcome Jessica McDougall

(July 2016)
Jessica will be running our ELISA tests under the supervision of our Laboratory Manager and pathologist Laboratory Director.

New Evidence Supports Serum HER2 Monitoring

(March 2016)
See a recent article published in the Journal of Clinical Oncology (Lee CK, et al, March 2016.)

New Office and Lab Space

(March 2014)

We have moved and are now located in Roseville, MN. This suburb of St. Paul is home to much of the large Minnesota medical device industry. 

Woman's Hospital Enters Service Agreement

(February 2014)
Woman's Hospital was an original beta site for the sHER2/neu test kit and is the largest breast cancer program in Baton Rouge, LA.